Oxaliplatin in Treating Patients With Advanced Head and Neck Cancer

NCT00005035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

OTHER

Sponsor class

Conditions

Head and Neck Cancer

Interventions

DRUG: oxaliplatin

Sponsor

Ohio State University Comprehensive Cancer Center

Collaborators

[object Object]